Impact of Tryptophan Catabolism on CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating ART Peter W. Hunt, Sheri Weiser, Yong Huang,

Slides:



Advertisements
Similar presentations
St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?
Advertisements

Metabolic consequences of HIV-induced inflammation Jacqueline Capeau INSERM U938, Université Pierre et Marie Curie Faculté de Médecine, site Saint-Antoine,
Miriam Lichtner Dipartimento di Malattie Infettive e Sanità Pubblica Sapienza Università di Roma Polo Pontino Componente dell Italian National Focal Point.
Antiretroviral Therapy: An HIV Prevention Strategy? Wafaa El-Sadr, MD, MPH Columbia University Harlem Hospital New York.
1 Severe morbidity among HIV- infected patients : a comparison between a Brazilian and a French clinic based observational cohort FIOCRUZ: Prof B Grinsztejn.
Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.
Immune-Based Interventions for HIV Infection and AIDS Alan Landay, PhD Professor and Chairman Department of Immunology/Microbiology Rush University Medical.
Women and HIV Lucille Sanzero Eller, PhD, RN Associate Professor Rutgers, The State University of New Jersey College of Nursing A Local Performance Site.
Tuberculosis incidence and risk factors among adult patients receiving HAART in Senegal: a 7-year cohort study Assane DIOUF et al. IRD/UMR 145 CRCF, CHNU.
Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.
HLA-B57 does not fully explain the ability of HIV controllers to clear HCV infection Alice K. Asher 1, RN, MS; Glenn-Milo Santos 1, MPH; Jennifer Evans,
The pathogenesis of persistent HIV-associated inflammation during long-term antiretroviral therapy Steven G. Deeks Professor of Medicine University of.
Impact of Active Tuberculosis on Immune Recovery in HIV-infected Individuals Receiving ART H.Y. Tan 1, Y.K. Yong 1, L.Y. Ong 1, Y.M. Lee 1, S.F.S. Omar.
Why is inflammation elevated in treated HIV infection and why does it matter? Steven G. Deeks Professor of Medicine University of California, San Francisco.
Protective HLA Class I alleles are associated with reduced immune activation in Primary HIV infection Elizabeth Hamlyn 1, Stephen Hickling 2, Abdel Babiker.
Role of Antiretroviral Therapy, Viral Replication, and HIV Infection in Atherosclerosis Priscilla Y. Hsue, Peter W. Hunt, Jeffrey N. Martin, Amanda Schnell,
Role of Adaptive vs. Innate Immune Activation in non-AIDS Morbidity Peter W. Hunt, MD Associate Professor of Medicine UCSF HIV/AIDS Division.
HDL Particles but not LDL Particles Predict Cardiovascular Disease Events in HIV Patients: Results from Strategies for Management of ART Study (SMART)
Cell- and Tissue-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1-Expressing CD4+ T cells H Hatano 1, V Jain 1, PW Hunt.
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy S. Fourati 1, R. Calin 2, G. Carcelain 3, P.
Long-term ART initiated during primary HIV-1 infection limits the HIV-1 reservoir size but not to levels found in LTNPs Eva Malatinkova, Ward De Spiegelaere,
Background There is uncertainty regarding the frequency, predictors, and outcomes of IRIS events Prior studies on IRIS have been limited to convenience.
The Immunologic Efficacy of Antiretroviral Therapy among HIV-infected Patients in North America and Africa Elvin Geng* 1, Eric Vittinghoff 1, Jean Nachega.
Impact of HSV-2 suppressive therapy with daily acyclovir on HIV-1 disease progression: a randomized placebo- controlled trial in Rakai, Uganda Steven J.
HIV i-Base: SMART Study & CROI Feedback UK-CAB - Feb 2006 UK-CAB 24 February 2006 CROI Feedback: SMART Study Simon Collins.
HIV/renal studies (CHIC) Baseline renal function as predictor of HIV/renal disease progression –Death, opportunistic infection –Severe chronic kidney disease.
Impact of Highly Active Antiretroviral Therapy on the Incidence of HIV- encephalopathy among perinatally- infected children and adolescents. Kunjal Patel,
T-Cell Senescence & Inflammation HIV Research Catalyst Forum, April
Life expectancy of patients treated with ART in the UK: UK CHIC Study Margaret May University of Bristol, Department of Social Medicine, Bristol.
HIV-1 infected subjects treated with an autologous dendritic cell therapy (AGS-004), exhibited a significant reduction in viral load (when compared to.
Neurocognitive Impairment in HIV-Infected Subjects on HAART: Prevalence and Associations Kevin Robertson *1, Kunling Wu 2, Thomas Parsons 1, Ron Ellis.
The Positive Predictive Value of World Health Organization (WHO) Immunologic Criteria for Treatment Failure in a Public Health Antiretroviral Delivery.
A structural approach to understanding the effect of loss to follow-up on epidemiologic analyses of HIV-infected patients on antiretroviral therapy in.
Primary HIV-1 Infection Pathogenesis, Diagnosis, and Treatment Summary of Evidence Martin Markowitz M.D. Clinical Director and Staff Investigator Aaron.
Twice Weekly Peg-IFN-alpha-2a with Ribavirin Improves Early Viral Kinetics over Standard Therapy Among HIV/HCV Co-Infected African American Patients Alison.
Factors Associated with Survival in HIV-Infected African Patients on Antiretroviral Therapy: The Impact of a Sampling-Based Approach to Address Losses.
Supported by: NIAID/NHLBI R24 AI067039, NIAID R21 AI Viremia copy-years: A measure of cumulative HIV burden among patients initiating antiretroviral.
Evidence for the link between markers of inflammation, coagulation and immune activation and end organ disease Session: Immune Activation/Inflammation.
Persistent immune activation despite suppressive HAART is associated with higher risk for viral blips in HIV-1 infected individuals Alexander Zoufaly 1.
Regulatory T cell abnormalities associated with aberrant CD4+ T-cell responses in HIV+ patients with immune reconstitution disease (IRD) Nabila SEDDIKI.
Potential Utility of Tipranavir in Current Clinical Practice Daniel R. Kuritzkes, MD Director of AIDS Research Brigham and Woman’s Hospital Division of.
Strategies for Management of Antiretroviral Therapy Study Wafaa El-Sadr and James Neaton for the SMART Study Team.
Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.
Effect of ART on malaria parasitaemia and clinical episodes in adults in rural Uganda: A population-based cohort study Billy N. Mayanja 1, Kathy Baisley.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
Diego Ripamonti - Malattie Infettive - Bergamo Simposio HOT TOPICS Hot topics in HIV 2015.
Slideset on: Emery S, Neuhaus JA, Phillips AN, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving.
The Dynamics of HIV RNA, CD4+ Count and Mycobacterium tuberculosis (Mtb) Antigen Specific Cytokines in TB/HIV Patients Following Successful Tuberculosis.
G. E. Martin. , N. Pantazis. , M. Hoffmann. , S. Hickling, J. Hurst, J
HIV Cure: Current Status and Future Perspectives
Higher rate of antiretroviral therapy reinitiation among HIV-HBV coinfected patients in the episodic arm of the SMART study Dore G.1, Soriano V.2, Neuhaus.
ART and toxicities: CNS
Validating Definitions of Antiretroviral Treatment Failure in Malawi
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
University Hospital Ulm, Germany
Juan Gonzalez Perez AIDS Healthcare Foundation
Urine neopterin concentrations as a marker for successful blastocyst implantation after assisted reproductive technologies  V. Melichar, E. Soelder, K.
The Aging Liver in the Aging HIV and HCV Patients
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load by Steven G. Deeks, Christina.
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Residual Disease and Immune Activation/Inflammation on ART
VACS Risk Index Refinement and further validation
Shawn L Fultz, MD MPH VACS Scientific Meeting, Feb 2004
Janine Bilsborough, Joanne L. Viney  Gastroenterology 
Andreas D. Haas, PhD Postdoctoral fellow, ICAP at Columbia University
Immunologic strategies for HIV-1 remission and eradication
Presentation transcript:

Impact of Tryptophan Catabolism on CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating ART Peter W. Hunt, Sheri Weiser, Yong Huang, Conrad Muzoora, Annet Kembabazi, Kathleen Ragland, John Bennett, Elvin Geng, Steven G. Deeks, David R. Bangsberg, Jeffrey N. Martin, and Joseph M. McCune

Background Immune activation persists in most HIV+ patients despite ART-mediated viral suppression This inflammatory state may contribute to morbidity/mortality during treated HIV infection. Demonstrating that specific inflammatory pathways predict subsequent clinical events is critical step in identifying therapeutic targets.

IDO-induced Tryptophan Catabolism IFN-γ and LPS stimulate Indoleamine 2,3-dioxygenase -1 (IDO) production in DCs/MØ Causes tryptophan catabolism Tryptophan depletion may impair T cell proliferation – Maternal tolerance of fetal antigens – Cancer evasion of immune response Catabolites may be neurotoxic – Neurodegenerative diseases, ADC Downstream catabolite 3- Hydroxyanthralinic Acid (HAA) causes Th17 depletion Favre, Mold et al, Science TM, 2010 IDO Kynurenine Tryptophan (K/T Ratio) = Marker of Tryptophan Catabolism

Impact of IDO Induction on HIV Pathogenesis IFN-γ LPS IDO Induction in DC/MØ Tryptophan T Cell Proliferative Defect Microbial Translocation HAA Th17 Depletion

Does the Extent of Tryptophan Catabolism Predict Subsequent Clinical Events During Treated HIV Infection? Cohort of 500 HIV-infected Ugandans starting first ART regimen (UARTO) Assessed plasma tryptophan and kynurenine levels through 1 st year of ART Assessed impact on subsequent CD4 recovery and mortality

Characteristics of HIV-infected Ugandans Starting ART Characteristic Median (IQR) N=435 Age, years34 (28-39) Female gender, %70 Pre-ART CD4+ T cell count, cells/mm (79-201) Pre-ART Plasma HIV RNA level, log 10 copies/ml5.0 ( ) Months of observation on ART38 (22-47) 8% Lost to follow up by month 36

Higher Baseline Tryptophan Catabolism Associated with Greater Early CD4 Recovery Though Largely Explained by Pre-ART VL No evidence for an association between K/T ratio and early CD4 recovery after adjustment for pre-ART VL (P=0.95)

But Higher Baseline Tryptophan Catabolism Predicts Diminished Late CD4 Recovery Higher pre-ART K/T ratio predicted diminished late CD4 recovery after adjustment for age, gender, and pre-ART VL and CD4 count (P=0.008)

Low Pre-ART CD4 Count Predicts Earlier Mortality

Higher Tryptophan Catabolism (K/T ratio) Predicts Earlier Mortality Each tertile increase in baseline K/T ratio associated with a 2.1-fold greater hazard of death after adjustment for pre-ART BMI and CD4 count (P=0.01).

Tryptophan Catabolism Decreases During ART Tryptophan LevelsK/T Ratio

Tryptophan Catabolism Continues to Predict Mortality during Suppressive ART (VL<400 at Month 6 of ART) Each tertile increase in month 6 K/T ratio associated with a 2.9-fold increased hazard of death after adjusting for BMI, CD4 count, and %CD38+HLA-DR+ CD8+ T cells (P=0.042).

Does dietary protein intake modify the relationship between tryptophan catabolism and mortality?

Low Protein Diet Might Exacerbate T Cell Proliferative Defects but Ameliorate Th17 Depletion Low Dietary Tryptophan IDO- induced Catabolism More Tryptophan Depletion More T Cell Proliferative Defects Less Microbial Translocation Less HAA Less Th17 Depletion

High Dietary Tryptophan IDO- induced Catabolism Less Tryptophan Deficiency Less T Cell Proliferative Defects More Microbial Translocation More HAA More Th17 Depletion High Protein Diet Might Ameliorate T Cell Proliferative Defects but Exacerbate Th17 Depletion Gal, J. Neurochemistry, 1978

Ugandan Diet is Low in Protein See also: Crawford et al, British Journal of Nutrition, 1970

Low Dietary Protein Intake Is Associated with Low Plasma Tryptophan Relationship remains significant even after adjustment for VL, CD4 count, gender, and BMI (P=0.021)

No Evidence for an Association Between Dietary Protein Intake and Mortality

Low Dietary Protein Does Not Appear to Exacerbate the Impact of Tryptophan Catabolism on Mortality

P for interaction = 0.34

Conclusions Among HIV-infected Ugandans, greater pre-ART tryptophan catabolism predicts a diminished rate of late CD4+ T cell recovery during suppressive ART. Tryptophan catabolism is a major independent predictor of mortality in HIV-infected Ugandans both pre-ART and during ART-mediated viral suppression. Interventions designed to block IDO induction (or the root causes of IDO induction) may hold promise in this setting.

Unanswered Questions Unclear if tryptophan catabolism is causally associated with disease or is simply another marker for monocyte and DC activation. – Testing of samples for other markers of monocyte and innate immune activation is ongoing to compare prognostic strength. Ultimately, the importance of IDO-mediated tryptophan catabolism in HIV pathogenesis will need to be established in clinical trials of specific IDO inhibitors.

Acknowledgements MUST-UARTO The participants Annet Kembabazi Derrick Musinga Simone Hausammann-Kigozi Bosco Bwana Conrad Muzoora UCSF - UARTO Elvin Geng Steven Deeks John Bennett Rain Mocello Jeffrey Martin MGH/Harvard - UARTO Anna Baylor Jessica Haberer Peggy Bartek David Bangsberg UARTO Team UCSF – Food Insecurity Kathleen Ragland Sheri Weiser UCSF – Laboratory Yong Huang Huyen Cao Joseph M. McCune Doris Duke CSDA, 1R21AI078774, R01MH054097